We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]
OUR IMPACT Osteoporosis Canada’s latest Impact Report is now available. This report highlights the organization’s significant achievements over the past year towards the vision of a Canada without osteoporotic fractures. […]
IMPACT REPORT 2018 – 2019 PATIENT STORY: MEET BRUCE SCAFE On the day after Bruce’s 60th birthday, he ran his very first marathon. It was months of training for the […]